Evaluation of HOMA and QUICKI as measures of insulin sensitivity in prepubertal children
Related Experiment Video
Updated: Aug 21, 2026

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)
Published on: January 7, 2018
Wayne S Cutfield1, Craig A Jefferies, Wendy E Jackson
1Department of Paediatrics and the Health Research Council Biostatistics Unit, University of Auckland, Private Bag 92019, Auckland, New Zealand. w.cutfield@auckland.ac.nz
Insights
Simple fasting methods like HOMA and QUICKI are unreliable for measuring insulin sensitivity in children. These methods failed to detect changes in insulin sensitivity related to obesity or growth hormone therapy in prepubertal children.
Area of Science:
- Pediatric Endocrinology
- Metabolic Research
- Clinical Diagnostics
Background:
- Insulin sensitivity (SI) assessment in children is crucial for metabolic health.
- Homeostasis model assessment (HOMA) and quantitative insulin-sensitivity check index (QUICKI) are widely used in adults but lack validation in pediatric populations.
- This study aimed to compare HOMA and QUICKI with the minimal model for SI measurement in prepubertal children.
Discussion:
- The study evaluated SI in a diverse group of prepubertal children, including twins, premature, and small for gestational age (SGA) infants.
- The minimal model (SIMM) was used as the gold standard for SI assessment, derived from frequently sampled intravenous glucose tolerance tests.
- HOMA resistance index (RHOMA) and QUICKI were calculated using fasting glucose and insulin levels.
Key Insights:
- RHOMA showed poor correlation with SIMM, comparable to fasting insulin alone, and was only significant at low SI values.
- QUICKI demonstrated a weak correlation with SIMM, indicating its inadequacy as an SI measure in this age group.
- Neither RHOMA nor QUICKI could detect significant changes in SI in response to growth hormone therapy in SGA children or differences between obese and non-obese children.
Outlook:
- Current simple fasting-based methods (HOMA, QUICKI) are not suitable for assessing insulin sensitivity in prepubertal children.
- The minimal model remains a more reliable method for evaluating SI dynamics in pediatric research.
- Further research is needed to develop and validate accurate, accessible SI assessment tools for pediatric populations.
Background:
Simple fasting sample methods to measure insulin sensitivity (SI) such as homeostasis model assessment (HOMA) and quantitative insulin-sensitivity check index (QUICKI) have been widely promoted in adult studies but have not been formally evaluated in children. The aim of this study was to compare HOMA and QUICKI to the minimal model as measures of SI in prepubertal children.
Method:
The study population consisted of twins (n = 44), premature (n = 17), small for gestational age (SGA) (15), and normal (n = 3) prepubertal children. The insulin-sensitivity index derived by the minimal model (SIMM) was calculated by the minimal model with plasma glucose and insulin data from a 90-min frequently sampled intravenous glucose test with tolbutamide. The HOMA resistance index (RHOMA) and QUICKI were calculated from fasting plasma glucose and insulin values.
Results:
The correlation between RHOMA and SIMM (r = -0.4, p < 0.001) was no better than that between fasting insulin and SIMM (r = -0.4, p < 0.001). QUICKI was poorly correlated with SIMM (r = 0.2, p = 0.02). The correlation between SIMM and RHOMA is largely confined to low SI values (< 10 x 10(-4)/min microU/mL.) In seven SGA subjects, the introduction of growth hormone treatment led to an expected fall in SIMM by 8.2 +/- 2.8 x 10(-4)/min microU/mL (p = 0.02) that was not detected by either RHOMA (p = 0.1) or QUICKI (p = 0.2). Similarly, SIMM values were lower in obese (n = 9) compared to non-obese subjects (p = 0.04); however, no difference was found between these two groups with either RHOMA (p = 0.21) or QUICKI (p = 0.8).
Conclusion:
As measures of SI in prepubertal children, RHOMA is no better than fasting insulin and QUICKI, a poor measure. Neither RHOMA nor QUICKI was able to detect changes in SI induced by either obesity or growth hormone therapy.
More Related Videos
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Hyperglycemia

